Which serum hormones should be measured on day 3 of the menstrual cycle and what are their normal reference ranges in a reproductive‑age woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cycle Day 3 Hormonal Profile

The essential hormones to measure on cycle day 3 (or days 3-6) of the menstrual cycle are FSH, LH, estradiol, prolactin, TSH, and free T4, with testosterone and AMH added based on clinical presentation. 1

Core Hormone Panel and Timing

Measure the following hormones between cycle days 3-6 of the menstrual cycle:

  • FSH (Follicle-Stimulating Hormone) 2, 3, 1
  • LH (Luteinizing Hormone) 3, 4, 1
  • Estradiol (E2) 2, 4, 1
  • Prolactin 2, 1
  • TSH and Free T4 1

Additional hormones based on clinical presentation:

  • Testosterone (if hirsutism, virilization, or suspected PCOS) 3, 1
  • AMH (Anti-Müllerian Hormone) (for ovarian reserve assessment) 2, 4, 1
  • Progesterone (measured mid-luteal phase, not day 3) 3, 1
  • DHEA-S (if hyperandrogenism suspected) 3, 1

Optimal Sampling Technique

For FSH and LH, obtain three blood samples 20 minutes apart and calculate the average for optimal accuracy. 3, 1 This approach minimizes the impact of pulsatile secretion and provides more reliable results than a single measurement.

Normal Reference Ranges for Reproductive-Age Women (Day 3)

FSH Reference Values

  • Normal range: 3.3-9.5 IU/L (women aged 20-25 years) 5
  • Normal range: 3.8-23.8 IU/L (women aged 40-45 years) 5
  • Median early follicular: 7.14 IU/L (range 4.78-13.2 IU/L) 6
  • Elevated FSH: >25 IU/L indicates premature ovarian insufficiency (POI) 2, 1

LH Reference Values

  • Normal range: 0.2-1.7 (LH/FSH ratio) in early follicular phase 7
  • Median early follicular: 7.14 IU/L (range 4.78-13.2 IU/L) 6
  • LH/FSH ratio >2 suggests PCOS 3, 1

Estradiol (E2) Reference Values

  • Normal range: 20.4-95.0 pg/mL (women aged 20-25 years) 5
  • Normal range: 22.4-122.8 pg/mL (women aged 40-45 years) 5
  • Median early follicular: 198 pmol/L (range 114-332 pmol/L) or approximately 54 pg/mL 6
  • Low estradiol: <20-50 pg/mL with elevated FSH indicates ovarian insufficiency 2, 1

Prolactin Reference Values

  • Normal: <20-25 µg/L 3, 1
  • Elevated: >20-25 µg/L indicates hyperprolactinemia 1

Testosterone Reference Values

  • Normal: <2.5 nmol/L 3, 1
  • Elevated: >2.5 nmol/L suggests PCOS or hyperandrogenism 3, 1

AMH Reference Values

  • Normal/adequate reserve: >1 ng/mL 1
  • Diminished reserve: <0.5-1 ng/mL 4, 1
  • Lower limit in peak reproductive age: 51.7 pg/mL 5

Critical Diagnostic Patterns

Premature Ovarian Insufficiency (POI)

  • FSH >25-35 IU/L (often 25-64 IU/L, average 37 IU/L) 2, 1
  • Estradiol <20-50 pg/mL 2, 1
  • AMH <0.5 ng/mL 1
  • Repeat testing after 1 month to confirm 2

Polycystic Ovary Syndrome (PCOS)

  • LH/FSH ratio >2 3, 1
  • Testosterone >2.5 nmol/L 3, 1
  • Normal or elevated AMH 1
  • Low progesterone <6 nmol/L (anovulation) 3, 1

Functional Hypothalamic Amenorrhea

  • Low-normal FSH and LH (<10 IU/L) 1
  • Low estradiol (<50 pg/mL) 1
  • Normal AMH (>1 ng/mL) 1

Hyperprolactinemia

  • Prolactin >20-25 µg/L 3, 1
  • Low-normal FSH and LH 1
  • Low estradiol 1

Critical Pitfalls and Caveats

Discontinue hormonal contraception at least 3 months before testing. Combined estrogen-progestin contraception or antigonadotropic progestins will significantly suppress FSH levels and invalidate results. 2, 1

Avoid post-ictal prolactin sampling. In women with epilepsy, prolactin must be measured as a morning resting level, not after a seizure. 3, 1

Repeat borderline FSH elevations (25-35 IU/L) after 1 month. FSH levels can vary between cycles, particularly in women aged 40-45 years, where 22% may have normal values in one cycle and elevated values in the next. 5, 8

Estradiol >150-200 pg/mL on day 3 suggests mid-cycle surge or estradiol-secreting cyst, not true baseline follicular phase values. 2, 1

Day 2 or day 4 sampling is acceptable if day 3 is unavailable. FSH varies by approximately 14.8% (coefficient of variation) between days 2-4, while estradiol varies more widely at 31.1%. 8

Reference ranges are assay-specific. Different laboratory methods produce different absolute values; clinicians must use local reference ranges. 6, 5, 9

References

Guideline

Guideline for Female Reproductive Hormone Testing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

reproductive dysfunction in women with epilepsy: recommendations for evaluation and management.

Journal of Neurology, Neurosurgery and Psychiatry, 2002

Related Questions

In a premenopausal woman with a regular menstrual cycle, does an estradiol level of 146 pg/mL and a luteinizing hormone (LH) level of 20 IU/L indicate that menstruation is imminent?
Does an estradiol level of 145 pmol/L and a luteinizing hormone level of 20 IU/L indicate that menstruation is imminent?
When is the optimal time to assess reproductive hormones (estradiol, follicle‑stimulating hormone, luteinizing hormone, testosterone, and progesterone) in a non‑pregnant adult woman not taking exogenous hormones?
What is the ideal timing for checking hormone levels in a 32-year-old female patient?
What is the expected level of Luteinizing Hormone (LH) on day 8 or 9 of the menstrual cycle?
Can a patient with latent autoimmune diabetes in adults (LADA) be treated with Jardiance (empagliflozin)?
What are the grades of diastolic dysfunction, what do they signify clinically, and what are the common causes?
Which silicone‑based barrier cream (e.g., Cavilon Barrier Cream, dimethicone) should be used for a resident with perianal soreness, no diarrhea, and current twice‑daily zinc‑oxide ointment (Desitin) application to prevent sacral redness from wiping?
For an adult with anxiety and trauma undergoing EMDR, is cannabis appropriate and what dosing, THC/CBD limits, and safety considerations should be followed?
Is it safe to switch a patient from nifedipine 10 mg (immediate‑release) to amlodipine 10 mg?
Can trazodone precipitate or worsen mania in patients with bipolar disorder?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.